BioLife Solutions PE Ratio 2010-2025 | BLFS
Current and historical p/e ratio for BioLife Solutions (BLFS) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BioLife Solutions PE ratio as of May 22, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BioLife Solutions PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-22 | 22.10 | 0.00 | |
| 2025-03-31 | 22.84 | $-0.29 | 0.00 |
| 2024-12-31 | 25.96 | $-0.50 | 0.00 |
| 2024-09-30 | 25.04 | $-1.06 | 0.00 |
| 2024-06-30 | 21.43 | $-1.69 | 0.00 |
| 2024-03-31 | 18.55 | $-1.42 | 0.00 |
| 2023-12-31 | 16.25 | $-1.52 | 0.00 |
| 2023-09-30 | 13.81 | $-2.37 | 0.00 |
| 2023-06-30 | 22.10 | $-1.93 | 0.00 |
| 2023-03-31 | 21.75 | $-3.41 | 0.00 |
| 2022-12-31 | 18.20 | $-3.26 | 0.00 |
| 2022-09-30 | 22.75 | $-2.48 | 0.00 |
| 2022-06-30 | 13.81 | $-2.25 | 0.00 |
| 2022-03-31 | 22.73 | $-0.35 | 0.00 |
| 2021-12-31 | 37.27 | $-0.21 | 0.00 |
| 2021-09-30 | 42.32 | $0.10 | 423.20 |
| 2021-06-30 | 44.51 | $0.06 | 741.83 |
| 2021-03-31 | 36.00 | $-0.83 | 0.00 |
| 2020-12-31 | 39.89 | $-0.81 | 0.00 |
| 2020-09-30 | 28.94 | $-0.73 | 0.00 |
| 2020-06-30 | 16.35 | $-0.32 | 0.00 |
| 2020-03-31 | 9.50 | $0.41 | 23.17 |
| 2019-12-31 | 16.18 | $0.44 | 36.77 |
| 2019-09-30 | 16.63 | $0.46 | 36.14 |
| 2019-06-30 | 16.95 | $0.14 | 121.07 |
| 2019-03-31 | 17.89 | $0.16 | 111.81 |
| 2018-12-31 | 12.03 | $0.13 | 92.54 |
| 2018-09-30 | 17.50 | $0.04 | 437.50 |
| 2018-06-30 | 11.41 | $-0.04 | 0.00 |
| 2018-03-31 | 5.13 | $-0.15 | 0.00 |
| 2017-12-31 | 6.00 | $-0.21 | 0.00 |
| 2017-09-30 | 5.71 | $-0.42 | 0.00 |
| 2017-06-30 | 2.39 | $-0.47 | 0.00 |
| 2017-03-31 | 2.09 | $-0.52 | 0.00 |
| 2016-12-31 | 1.61 | $-0.55 | 0.00 |
| 2016-09-30 | 1.84 | $-0.38 | 0.00 |
| 2016-06-30 | 1.60 | $-0.39 | 0.00 |
| 2016-03-31 | 1.83 | $-0.36 | 0.00 |
| 2015-12-31 | 2.17 | $-0.35 | 0.00 |
| 2015-09-30 | 2.11 | $-0.34 | 0.00 |
| 2015-06-30 | 1.95 | $-0.32 | 0.00 |
| 2015-03-31 | 1.61 | $-0.31 | 0.00 |
| 2014-12-31 | 1.64 | $-0.32 | 0.00 |
| 2014-09-30 | 2.10 | $-0.34 | 0.00 |
| 2014-06-30 | 2.28 | $-0.27 | 0.00 |
| 2014-03-31 | 3.69 | $-0.20 | 0.00 |
| 2013-12-31 | 8.40 | $-0.10 | 0.00 |
| 2013-09-30 | 11.13 | $-0.14 | 0.00 |
| 2013-06-30 | 5.04 | $-0.28 | 0.00 |
| 2013-03-31 | 4.06 | $-0.42 | 0.00 |
| 2012-12-31 | 4.76 | $-0.42 | 0.00 |
| 2012-09-30 | 1.82 | $-0.42 | 0.00 |
| 2012-06-30 | 1.26 | $-0.42 | 0.00 |
| 2012-03-31 | 1.40 | $-0.42 | 0.00 |
| 2011-12-31 | 0.70 | $-0.56 | 0.00 |
| 2011-09-30 | 1.12 | $-0.56 | 0.00 |
| 2011-06-30 | 1.12 | $-0.56 | 0.00 |
| 2011-03-31 | 1.12 | $-0.56 | 0.00 |
| 2010-12-31 | 0.77 | $-0.56 | 0.00 |
| 2010-09-30 | 1.19 | $-0.56 | 0.00 |
| 2010-06-30 | 1.33 | $-0.56 | 0.00 |
| 2010-03-31 | 1.41 | $-0.56 | 0.00 |
| 2009-12-31 | 1.54 | $-0.56 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.049B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.059B | 0.00 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Insulet (PODD) | United States | $22.837B | 89.64 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.436B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.173B | 14.11 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |